Key facts
- This page summarizes Robert Gut's Form 4 filing for uniQure N.V. (QURE).
- 8 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2026, 18:04.
Robert Gut - 10 Jun 2026 Form 4 Insider Report for uniQure N.V. (QURE)
- Reporting relationship
- Director
- Issuer ticker
- QURE
- Reported as of
- 10 Jun 2026
- Net transaction value
- -$270,486
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2026, 18:04:09 UTC
- Prior SEC filing
- 14 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Klemt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Gut filed Form 4 for uniQure N.V. (QURE) on 12 Jun 2026.
Change
- Previous filing in this sequence was filed on 14 Jan 2026.
- Current net transaction value: -$270,486.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001716268
Primary reporting owner
Gut Robert
- Relationship
- Director
- Address
- C/O UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM, NETHERLANDS
- Signature
- /s/ Christian Klemt, Attorney-in-Fact
- Signature date
- 12 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QURE
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +2,645
- Change %
- +8.2%
- Price
- $16.04*
- Shares after
- 34,987
- Date
- 10 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
QURE
transaction
Ordinary Shares
Sale
- Transaction value
- $68,955
- Shares
- -2,645
- Change %
- -7.6%
- Price
- $26.07
- Shares after
- 32,342
- Date
- 10 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
QURE
transaction
Ordinary Shares
Sale
- Transaction value
- $81,396
- Shares
- -3,127
- Change %
- -9.7%
- Price
- $26.03
- Shares after
- 29,215
- Date
- 10 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F3
QURE
transaction
Ordinary Shares
Sale
- Transaction value
- $46,369
- Shares
- -1,780
- Change %
- -6.1%
- Price
- $26.05
- Shares after
- 27,435
- Date
- 10 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F4
QURE
transaction
Ordinary Shares
Award
- Transaction value
- Shares
- +7,550
- Change %
- +28%
- Price
- $0.000000*
- Shares after
- 34,985
- Date
- 10 Jun 2026
- Ownership
- Direct
- Footnotes
- F5
QURE
transaction
Ordinary Shares
Sale
- Transaction value
- $73,766
- Shares
- -2,726
- Change %
- -7.8%
- Price
- $27.06
- Shares after
- 32,259
- Date
- 11 Jun 2026
- Ownership
- Direct
- Footnotes
- F6, F7
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QURE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -2,645
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Jun 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,645
- Exercise price
- $16.04
- Footnotes
- F1, F8
QURE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +13,980
- Change %
- Price
- $0.000000*
- Shares after
- 13,980
- Date
- 10 Jun 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 13,980
- Exercise price
- $26.82
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 9 footnotes
Footnote F1
The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
Footnote F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
Footnote F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
Footnote F5
Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
Footnote F6
The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
Footnote F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
Footnote F8
The Stock Option vested in full on February 24, 2023.
Footnote F9
The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.